Status: Not yet recruiting
Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.
Participants needed: 50
Trial details
Age: 35+Biological sex: FemaleType: ObservationalSponsor: University of British ColumbiaUpdated: May 12, 2026Locations: 1
Eligibility criteria
35 years and older [+1]
Currently pregnant or become pregnant during their participation [+2]